Clinical Advisory Board
Imagen Therapeutics is committed to providing an accurate, reliable and innovative chemosensitivity testing service to deliver precise, personalised medicine. We are establishing a handpicked Clinical Advisory Board to help us to achieve this aim.
Professor Justin Stebbing
Honorary Medical Advisor
Professor Justin Stebbing trained in medicine at Trinity College Oxford, where he gained a first class degree in Physiological Sciences. After completion of junior doctor posts in Oxford, he undertook junior doctor training and a residency at The Johns Hopkins Hospital in the US, returning to London to continue his career in oncology at The Royal Marsden and then St Bartholomew's Hospitals. Professor Stebbing’s original PhD research investigated the interplay between the immune system and cancer. Professor Stebbing has published over 500 peer-reviewed papers in journals such as the Lancet, New England Journal, Blood, the Journal of Clinical Oncology, Annals of Internal Medicine, as well as writing regularly for national newspapers and presenting new data on optimal cancer therapies at the major international conferences. He is the deputy editor of Oncogene and is particularly interested in the challenge of optimizing chemotherapy for patients and Imagen Therapeutics’ approach to this difficult problem.